The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin
Open accessAbstract
Most strains of Pseudomonas aeruginosa are significantly more resistant, even in the absence of R plasmids, to many antimicrobial agents, including beta-lactams, tetracycline, chloramphenicol, and fluoroquinolones, than most other gram-negative rods. This broad-range resistance has so far been assumed to be mainly due to the low permeability of the P. aeruginosa outer membrane. The intrinsic-resistance phenotype becomes further enhanced in "intrinsically carbenicillin-resistant" isolates, which were often assumed to produce outer membranes of even lower permeability. It has been shown, however, that this hypothesis cannot explain the beta-lactam resistance of these isolates (D.M. Livermore and K.W.M. Davy, Antimicrob. Agents Chemother. 35:916-921, 1991). In this study, we examined the uptake of tetracycline, chloramphenicol, and norfloxacin by intact cells using strains showing widely different levels of intrinsic resistance. Their accumulation and the response to the addition of a proton conductor showed that even relatively susceptible strains of P. aeruginosa actively pump out these compounds from the cell and that the efflux activity becomes much stronger in strains showing higher levels of intrinsic resistance. We conclude that the efflux mechanism(s) are likely to contribute significantly to the intrinsic resistance of P. aeruginosa isolates to tetracycline, chloramphenicol, and fluoroquinolones, as does the low permeability of the outer membrane. This conclusion is supported by the observation that the hypersusceptibility to various agents of the mutant K799/61 (W. Zimmermann, Antimicrob. Agents Chemother. 18:94-100, 1980) was apparently caused by the lack of active efflux. Although the hypersusceptibility of this mutant has hitherto been assumed to be solely due to its higher outer membrane permeability, its outer membrane was shown to have a coefficient of permeability to cephaloridine that was not significantly different from that of the parent, resistant strain K799/WT. The strains with elevated intrinsic resistance overproduced two cytoplasmic membrane proteins and one outer membrane protein; at least two of these proteins appeared different from the proteins overproduced in the recently described mutant with a derepressed multidrug efflux system, MexA-MexB-OprK (K. Poole, K. Krebes, C. McNally, and S. Neshat, J. Bacteriol. 175:7363-7372, 1993).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular basis of bacterial outer membrane permeability
Nikaido, H., & Vaara, M. (1985) · Microbiological Reviews · doi:10.1128/mmbr.49.1.1-32.1985 · Cited by 2,447
Self-citationPrevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
Self-citationPoole, K., Krebes, K., McNally, C., & Neshat, S. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.22.7363-7372.1993 · Cited by 688
McMurry, L., Petrucci, R. E., & Levy, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3974 · Cited by 604
Active efflux mechanisms for antimicrobial resistance
Levy, S. B. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.4.695 · Cited by 503
Molecular cloning and characterization of acrA and acrE genes of Escherichia coli
Ma, D., Cook, D. N., Alberti, M., Pon, N. G., Nikaido, H., & Hearst, J. E. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.19.6299-6313.1993 · Cited by 466
Self-citationOuter membrane barrier as a mechanism of antimicrobial resistance
Nikaido, H. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.11.1831 · Cited by 462
Self-citationEmr, an Escherichia coli locus for multidrug resistance.
Lomovskaya, O., & Lewis, K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.8938 · Cited by 424
Cohen, S. P., Hächler, H., & Levy, S. B. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.5.1484-1492.1993 · Cited by 388
Outer membrane of Salmonella typhimurium
Nikaido, H. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90182-6 · Cited by 377
Self-citationCohen, S. P., McMurry, L. M., Hooper, D. C., Wolfson, J. S., & Levy, S. B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1318 · Cited by 376
Neyfakh, A. A., Bidnenko, V. E., & Chen, L. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4781 · Cited by 371
Substrate specificity and transport properties of the glycerol facilitator of Escherichia coli
Heller, K. B., Lin, E. C., & Wilson, T. H. (1980) · Journal of Bacteriology · doi:10.1128/jb.144.1.274-278.1980 · Cited by 331
Nikaido, H., & Thanassi, D. G. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.7.1393 · Cited by 280
Self-citationLi, X. Z., Ma, D., Livermore, D. M., & Nikaido, H. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1742 · Cited by 278
Self-citationPermeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes
Yoshimura, F., & Nikaido, H. (1982) · Journal of Bacteriology · doi:10.1128/jb.152.2.636-642.1982 · Cited by 274
Self-citationAngus, B. L., Carey, A. M., Caron, D. A., Kropinski, A. M., & Hancock, R. E. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.2.299 · Cited by 262
Routes of quinolone permeation in Escherichia coli
Chapman, J. S., & Georgopapadakou, N. H. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.4.438 · Cited by 253
Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa
Masuda, N., & Ohya, S. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.1847 · Cited by 215
Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa
Hirai, K., Suzue, S., Irikura, T., Iyobe, S., & Mitsuhashi, S. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.4.582 · Cited by 201
Nikaido, H., & Normark, S. (1987) · Molecular Microbiology · doi:10.1111/j.1365-2958.1987.tb00523.x · Cited by 180
Self-citationOuter membranes of Gram‐negative bacteria are permeable to steroid probes
Plésiat, P., & Nikaido, H. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb00853.x · Cited by 180
Self-citationEndogenous active efflux of norfloxacin in susceptible Escherichia coli
Cohen, S. P., Hooper, D. C., Wolfson, J. S., Souza, K. S., McMurry, L. M., & Levy, S. B. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.8.1187 · Cited by 170
Rella, M., & Haas, D. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.2.242 · Cited by 167
New norfloxacin resistance gene in Pseudomonas aeruginosa PAO
Fukuda, H., Hosaka, M., Hirai, K., & Iyobe, S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.9.1757 · Cited by 149
Livermore, D. M., & Yang, Y.-J. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/155.4.775 · Cited by 122
Self-citationMühlradt, P. F., Menzel, J. E., Golecki, J. R., & Speth, V. (1974) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1974.tb03440.x · Cited by 118
Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO
Robillard, N. J., & Scarpa, A. L. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.4.535 · Cited by 103
Kropinski, A. M., Kuzio, J., Angus, B. L., et al. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.2.310 · Cited by 91
McMurry, L. M., George, A. M., & Levy, S. B. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.542 · Cited by 77
Legakis, N. J., TZOUVELEKIS, L. S., Makris, A. M., & Kotsifaki, H. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.1.124 · Cited by 73
Mechanisms of beta-lactam resistance in british isolates of Pseudomonas aeruginosa
WILLIAMS, R. J., Livermore, D. M., Lindridge, M., Said, A. A., & Williams, J. D. (1984) · Journal of Medical Microbiology · doi:10.1099/00222615-17-3-283 · Cited by 68
Self-citationFactors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa
Celesk, R. A., & Robillard, N. J. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.11.1921 · Cited by 58
Livermore, D. M. (1984) · Journal of Medical Microbiology · doi:10.1099/00222615-18-2-261 · Cited by 53
Self-citationLivermore, D. M., & Davy, K. W. M. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.5.916 · Cited by 24
Self-citationOuter membrane changes in quinolone resistant Pseudomonas aeruginosa
HASHMI, Z. S., & Smith, J. M. B. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/28.3.465 · Cited by 9
Cited by
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
Govan, J. R. W., & Deretic, V. P. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.3.539-574.1996 · Cited by 1,812
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Self-citationMultidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,522
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231
Metadata
- Authors
- Li, X. Z., Livermore, D. M., & Nikaido, H.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1994-08
- Volume
- 38
- Issue
- 8
- Pages
- 1732-1741
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2064163165
- Cited by
- 402
- References
- 36
- FWCI
- 12.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.